Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

The research developed new fortilin protein constructs for potential heart disease treatments.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Finasteride may help improve certain brain function issues linked to dopamine.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

GI197111X is best dissolved in Capmul MCM for trials.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.